Mechanistically, HCP5 is confirmed to target miR-3619-5p, facilitating FAO by activating AMPK/PGC1α/CEBPB axis to promote stemness and concomitantly mediate chemoresistance in GC cells (Wu et al., 2020). The gene discussed is HCP5; the disease is gastric cancer.